SV

Street Verdict

Analyst Scorecard

A record of what Ganesh Dongre said publicly, with the source. Not advice.

“Recommends buying Sun Pharma at ₹1785 with a stop loss at ₹1740 and a target price of ₹1850. This call is for Monday, April 28.”

Ganesh Dongre’s track record (trackable calls only): 327 graded calls · 95% CI 33–44%

Sun Pharmaceutical Industries Ltd.BullishCalled 27 Apr 2025Graded 12 May 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,785, as stated.

Target ₹1,850, stop ₹1,740, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,850 or ₹1,740: there is no fixed window.

The stop ₹1,740 was reached on a close before the target ₹1,850. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1785 on 2025-04-28 (stated entry ₹1785, LEVEL_CMP entry, filled); stop ₹1740 breached at close ₹1686.2 on 2025-05-12. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Sun Pharmaceutical Industries Ltd. since this call

1-year tracking window
Read the original articleSee Ganesh Dongre’s full track record